A $250,000 philanthropic grant from the Max Bell Foundation will allow McMaster researchers to test a new app designed to support stroke survivors using home care services.
When a patient leaves the hospital after a stroke, he or she may need a home care coordinator, a nurse, an occupational therapist, a physiotherapist, and a personal support worker. But there are often crucial delays and gaps in information-sharing among the many different service providers – and between patients and their health care team.
Researchers from McMaster's Aging, Community and Health Research Unit (ACHRU) in the School of Nursing have developed My Stroke Team (MyST), an app that enables home care workers to share information in real time, while also empowering stroke patients to actively participate in their own care.
Paul O’Byrne is a gentleman and a scholar who leads by example and is known for his honesty, intellect, calmness, kindness and supportive nature.
That was the description of O’Byrne given by many speakers at an event this week in tribute to his 14 years as the chair of McMaster’s Department of Medicine.
More than 200 current and past members of the University’s biggest department, as well as O'Byrne's family, attended the reception at the David Braley Health Sciences Centre, which was hosted by acting chair Akbar Panju. O’Byrne began his new role as the dean and vice-president of the Faculty of Health Sciences in July.
Judah Denburg and Warren Foster have joined 19 other Faculty of Health Sciences faculty members as fellows of the Canadian Academy of Health Sciences (CAHS).
Fellows elected to the Academy are recognized by their peers for outstanding contributions to the promotion of health science. Membership is considered one of the highest honours for individuals in the Canadian health sciences community.
Denburg is world-renowned for his expertise in autoimmune diseases, such as systemic lupus erythematosus (SLE), and for his groundbreaking research on the mechanisms of allergic inflammation and the development of allergic disease and asthma through the study of cord blood stem cells. As well, he is the founding scientific director and CEO of the Allergy, Genes & Environment Network (AllerGen). He is a professor of medicine and chief of service of the Division of Clinical Immunology & Allergy.